MINAPHARM Pharmaceuticals (EGX:MIPH)
Egypt · Delayed Price · Currency is EGP 766.83
-8.38 (-1.08%)
At close: Aug 25, 2026
MINAPHARM Pharmaceuticals Revenue
MINAPHARM Pharmaceuticals had revenue of 1.82B EGP in the quarter ending March 31, 2026, with 13.16% growth. This brings the company's revenue in the last twelve months to 6.65B, up 6.86% year-over-year. In the year 2025, MINAPHARM Pharmaceuticals had annual revenue of 6.44B with 14.97% growth.
Revenue (ttm)
6.65B
Revenue Growth
+6.86%
P/S Ratio
1.36
Revenue / Employee
n/a
Employees
n/a
Market Cap
9.03B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 6.44B | 838.51M | 14.97% |
| Dec 31, 2024 | 5.60B | 1.71B | 43.87% |
| Dec 31, 2023 | 3.89B | 271.51M | 7.50% |
| Dec 31, 2022 | 3.62B | 615.19M | 20.47% |
| Dec 31, 2021 | 3.01B | 644.34M | 27.29% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.